<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>kinaz hedefleme &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/kinaz-hedefleme/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 12 Jan 2026 16:06:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>kinaz hedefleme &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Targeting SPAK Halts Liver Cancer Progression, Boosts Immunity</title>
		<link>https://bioengineer.org/targeting-spak-halts-liver-cancer-progression-boosts-immunity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 12 Jan 2026 16:05:53 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[immün direnç]]></category>
		<category><![CDATA[immünoterapi kombinasyonu** **Açıklama:** 1. **SPAK inhibisyonu:** Makalenin ana konusu ve keşfedilen terapötik strateji. 2.]]></category>
		<category><![CDATA[İşte içerik için 5 uygun etiket (Türkçe): **SPAK inhibisyonu]]></category>
		<category><![CDATA[karaciğer kanseri tedavisi]]></category>
		<category><![CDATA[kinaz hedefleme]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeting-spak-halts-liver-cancer-progression-boosts-immunity/</guid>

					<description><![CDATA[In the relentless battle against hepatocellular carcinoma (HCC), one of the deadliest and most insidious forms of liver cancer, recent groundbreaking research has illuminated a promising therapeutic target that could redefine treatment paradigms. The 2026 landmark study led by Pan, Zeng, He, and colleagues, published in Nature Communications, unveils the critical role of the STE20/SPS1-related [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">316178</post-id>	</item>
	</channel>
</rss>
